Use of Topiramate in Treatment-Resistant Bipolar Spectrum Disorders (English)
- New search for: Vieta, E.
- New search for: Torrent, C.
- New search for: Garcia-Ribas, G.
- New search for: Gilabert, A.
- New search for: Garcia-Pares, G.
- New search for: Rodriguez, A.
- New search for: Cadevall, J.
- New search for: Garcia-Castrillon, J.
- New search for: Lusilla, P.
- New search for: Arrufat, F.
- New search for: Vieta, E.
- New search for: Torrent, C.
- New search for: Garcia-Ribas, G.
- New search for: Gilabert, A.
- New search for: Garcia-Pares, G.
- New search for: Rodriguez, A.
- New search for: Cadevall, J.
- New search for: Garcia-Castrillon, J.
- New search for: Lusilla, P.
- New search for: Arrufat, F.
In:
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
;
22
;
431-435
;
2002
-
ISSN:
- Article (Journal) / Print
-
Title:Use of Topiramate in Treatment-Resistant Bipolar Spectrum Disorders
-
Contributors:Vieta, E. ( author ) / Torrent, C. ( author ) / Garcia-Ribas, G. ( author ) / Gilabert, A. ( author ) / Garcia-Pares, G. ( author ) / Rodriguez, A. ( author ) / Cadevall, J. ( author ) / Garcia-Castrillon, J. ( author ) / Lusilla, P. ( author ) / Arrufat, F. ( author )
-
Published in:JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY ; 22 ; 431-435
-
Publisher:
- New search for: WILLIAMS & WILKINS
-
Publication date:2002-01-01
-
Size:5 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 615.78
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 615.78 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 22
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1
-
New Designs for Studies of the Prophylaxis of Bipolar DisorderPost, R. M. / Keck, P. / Rush, A. J. et al. | 2002
- 4
-
Shifting From Haloperidol to Risperidone for Behavioral Disturbances in Dementia: Safety, Response Predictors, and Mood EffectsLane, H.-Y. / Chang, Y.-C. / Su, M.-H. / Chiu, C.-C. / Huang, M.-C. / Chang, W.-H. et al. | 2002
- 11
-
Medication Management Ability Assessment: Results From a Performance-Based Measure in Older Outpatients With SchizophreniaPatterson, T. L. / Lacro, J. / McKibbin, C. L. / Moscona, S. / Hughs, T. / Jeste, D. V. et al. | 2002
- 20
-
Double-Blind, Placebo-Controlled Comparison of the Efficacy of Sertraline as Treatment for a Major Depressive Episode in Patients With Remitted SchizophreniaAddington, D. / Addington, J. / Patten, S. / Remington, G. / Moamai, J. / Labelle, A. / Beauclair, L. et al. | 2002
- 26
-
Tardive Dyskinesia Among Chinese and Malay Patients With SchizophreniaChong, S.-A. / Mahendran, R. / Machin, D. / Chua, H.-C. / Parker, G. / Kane, J. et al. | 2002
- 31
-
Risperidone in the Treatment of Tourette Syndrome: A Double-Blind, Placebo-Controlled TrialDion, Y. / Annable, L. / Sandor, P. / Chouinard, G. et al. | 2002
- 40
-
Severity of Depression and Response to Antidepressants and Placebo: An Analysis of the Food and Drug Administration DatabaseKhan, A. / Leventhal, R. M. / Khan, S. R. / Brown, W. A. et al. | 2002
- 46
-
Decreased Plasma Levels of Amitriptyline and Its Metabolites on Comedication With an Extract from St. John's Wort (Hypericum perforatum)Johne, A. / Schmider, J. / Brockmoller, J. / Stadelmann, A. M. / Stormer, E. / Bauer, S. / Scholler, G. / Langheinrich, M. / Roots, I. et al. | 2002
- 55
-
Mood Changes During Predinisone Bursts in Outpatients With AsthmaBrown, E. S. / Suppes, T. / Khan, D. A. / Carmody, T. J. et al. | 2002
- 62
-
Cognitive Effects of 10 Years of Hormone-Replacement Therapy With TiboloneFluck, E. / File, S. E. / Rymer, J. et al. | 2002
- 68
-
The Effect of Orslistat on Plasma Levels of Psychotropic Drugs in Patients With Long-term PsychopharmacotherapyHilger, E. / Quiner, S. / Ginzel, I. / Walter, H. / Saria, L. / Barnas, C. et al. | 2002
- 71
-
Antimicrobial-Induced Mania (Antibiomania): A Review of Spontaneous ReportsAbouesh, A. / Stone, C. / Hobbs, W. R. et al. | 2002
- 82
-
The alpha~1-Adrenergic Antagonist Prazosin Improves Sleep and Nightmares in Civilian Trauma Posttraumatic Stress DisorderTaylor, F. / Raskind, M. A. et al. | 2002
- 86
-
Increased Depressive Ratings in Patients With Hepatitis C Receiving Interferon-alpha-Based Immunotherapy Are Related to Interferon-alpha-Induced Changes in the Serotonergic SystemBonaccorso, S. / Marino, V. / Puzella, A. / Pasquini, M. / Biondi, M. / Artini, M. / Almerighi, C. / Verkerk, R. / Meltzer, H. / Maes, M. et al. | 2002
- 91
-
High-Dose Clozapine IntoxicationSartorius, A. / Hewer, W. / Zink, M. / Henn, F. A. et al. | 2002
- 92
-
Increased Plasma Concentration of Maprotiline by Coadministration of RisperidoneNorman, C. / Lieb, K. / Walden, J. et al. | 2002
- 94
-
Are the Atypical Antipsychotic Drugs Antidepressants?Parker, G. / Malhi, G. et al. | 2002
- 95
-
Nefazodone May Increase Anxiety in Panic DisorderStrohle, A. / Ehrenthal, H.-D. et al. | 2002
- 96
-
Is Sexual Dysfunctioning a Reason for Discontinuation in Users of Selective Serotonin Reuptake Inhibitors?Meijer, W. E. E. / Egberts, A. C. G. / Leufkens, H. G. M. / Waldinger, M. D. et al. | 2002
- 98
-
Paroxetine Modulates Psychological and Sympathetic Responses During Public SpeakingGolding, M. / Kotlyar, M. / Garbutt, J. C. / Guzzo, J. / Sontz, E. / Hinderliter, A. / Carson, S. W. et al. | 2002
- 100
-
Valproate Therapy for Chronic, Combat-Induced Posttraumatic Stress DisorderPetty, F. / Davis, L. L. / Nugent, A. L. / Kramer, G. L. / Teten, A. / Schmitt, A. / Stone, R. C. et al. | 2002
- 103
-
GUEST EDITORIAL: Mast Cells and Stress-A Psychoneuroimmunological PerspectiveTheoharides, T. C. et al. | 2002
- 109
-
The Effects of Antipsychotic-Induced Hyperprolactinaemia on the Hypothalamic-Pituitary-Gonadal AxisSmith, S. / Wheeler, M. J. / Murray, R. / O Keane, V. et al. | 2002
- 115
-
Would a Switch From Typical Antipsychotics to Risperidone Be Beneficial for Elderly Schizophrenic Patients? A Naturalistic, Long-Term, Retrospective, Comparative StudyBarak, Y. / Shamir, E. / Weizman, R. et al. | 2002
- 121
-
The Safety and Pharmacokinetics of Quetiapine When Coadministered With Haloperidol, Risperidone, or ThioridazinePotkin, S. G. / Thyrum, P. T. / Alva, G. / Bera, R. / Yeh, C. / Arvanitis, L. A. et al. | 2002
- 131
-
Serotonin and Fluoxetine Levels in Plasma and Platelets After Fluoxetine Treatment in Depressive PatientsBlardi, P. / De Lalla, A. / Leo, A. / Auteri, A. / Iapichino, S. / Di Muro, A. / Dell Erba, A. / Castrogiovanni, P. et al. | 2002
- 137
-
Acute Efficacy of Fluoxetine Versus Sertraline and Paroxetine in Major Depressive Disorder Including Effects of Baseline InsomniaFava, M. / Hoog, S. L. / Judge, R. A. / Kopp, J. B. / Nilsson, M. E. / Gonzales, J. S. et al. | 2002
- 148
-
Sertraline and Fluoxetine Treatment of Obsessive-Compulsive Disorder: Results of a Double-Blind, 6-Month Treatment StudyBergeron, R. / Ravindran, A. V. / Chaput, Y. / Goldner, E. / Swinson, R. / van Ameringen, M. A. / Austin, C. / Hadrava, V. et al. | 2002
- 155
-
Specific Side Effects of Long-Term Imipramine Management of Panic DisorderMavissakalian, M. / Perel, J. / Guo, S. et al. | 2002
- 162
-
In Vitro Inhibition of Pimozide N-Dealkylation by Selective Serotonin Reuptake Inhibitors and AzithromycinDesta, Z. / Soukhova, N. / Flockhart, D. A. et al. | 2002
- 169
-
Differential Time Course of Cytochrome P450 2D6 Enzyme Inhibition by Fluoxetine, Sertraline, and Paroxetine in Healthy VolunteersListon, H. L. / DeVane, C. L. / Boulton, D. W. / Risch, S. C. / Markowitz, J. S. / Goldman, J. et al. | 2002
- 174
-
Effect of Fluoxetine and Imipramine on the Pharmacokinetics and Tolerability of the Antipsychotic QuetiapinePotkin, S. G. / Thyrum, P. T. / Alva, G. / Carreon, D. / Yeh, C. / Kalali, A. / Arvanitis, L. A. / Pharmacokinetic Study Group et al. | 2002
- 183
-
Placebo-Controlled Comparison of Three Dose-Regimens of 5-Hydroxytryptophan Challenge Test in Healthy VolunteersGijsman, H. J. / van Gerven, J. M. A. / de Kam, M. L. / Schoemaker, R. C. / Pieters, M. S. M. / Weemaes, M. / de Rijk, R. / van der Post, J. / Cohen, A. F. et al. | 2002
- 190
-
Double-Blind Placebo-Controlled Pilot Study of Sertraline in Military Veterans With Post-traumatic Stress DisorderZohar, J. / Amital, D. / Miodownik, C. / Kotler, M. / Bleich, A. / Lane, R. M. / Austin, C. et al. | 2002
- 196
-
Treatment Predictors of Extrapyramidal Side Effects in Patients With Tardive Dyskinesia: Results From Veterans Affairs Cooperative Study 394Lohr, J. B. / Caligiuri, M. P. / Edson, R. / Lavori, P. / Adler, L. A. / Rotrosen, J. / Hitzemann, R. / Veterans Affairs Cooperative Study 394 Study Group et al. | 2002
- 201
-
The Effect of Multiple Doses of Cimetidine on the Steady-State Pharmacokinetics of Quetiapine in Men With Selected Psychotic DisordersStrakowski, S. M. / Keck, P. E. / Wong, Y. W. J. / Thyrum, P. T. / Yeh, C. et al. | 2002
- 206
-
The Anxiolytic Effect of the Novel Antipsychotic Ziprasidone Compared With Diazepam in Subjects Anxious Before Dental SurgeryWilner, K. D. / Anziano, R. J. / Johnson, A. C. / Miceli, J. J. / Fricke, J. R. / Titus, C. K. et al. | 2002
- 211
-
Paroxetine Increases Steady-State Concentrations of (R)-Methadone in CYP2D6 Extensive but Not Poor MetabolizersBegre, S. / von Bardeleben, U. / Ladewig, D. / Jaquet-Rochat, S. / Cosendai-Savary, L. / Golay, K. P. / Kosel, M. / Baumann, P. / Eap, C. B. et al. | 2002
- 216
-
Double-Blind, Placebo-Controlled Study of Single-Dose Metergoline in Depressed Patients With Seasonal Affective DisorderTurner, E. H. / Schwartz, P. J. / Lowe, C. H. / Nawab, S. S. / Feldman-Naim, S. / Drake, C. L. / Myers, F. S. / Barnett, R. L. / Rosenthal, N. E. et al. | 2002
- 221
-
Acute Stress-Induced Seizures and Loss of Consciousness in a Ten-Year-Old Boy With Cutaneous MastocytosisPehlivanidis, C. / Fotoulaki, M. / Boucher, W. / Kempuraj, D. / Pang, X. / Konstantinidou, A. / Theoharides, T. C. et al. | 2002
- 224
-
Effects of Oral Procyclidine Administration on Cognitive Functions in Healthy Subjects: Implications for SchizophreniaZachariah, E. / Kumari, V. / Galea, A. / Das, M. / Mehrotra, R. / Taylor, D. / Ruprah, M. / Sharma, T. et al. | 2002
- 226
-
Donepezil Management of Schizophrenia With Associated DementiaStryjer, R. / Bar, F. / Strous, R. D. / Baruch, Y. / Rabey, J. M. et al. | 2002
- 229
-
Amitriptyline and Paroxetine: Effects Upon Peripheral Nervous System (PNS)Henning, O. / Niedermaier, N. / Kniest, A. / Heuser, I. / Deuschle, M. et al. | 2002
- 231
-
Pathologic Laughter Associated With Paroxetine TreatmentZullino, D. / Lyon, I. / Morena, P. / Baumann, P. et al. | 2002
- 231
-
Conservative Management With Naltrexone of an Iatrogenic Methadone Overdose in an Opiate-Naive PatientDhopesh, V. / Yu, E. / Fudala, P. J. et al. | 2002
- 233
-
Possible Duplicate PublicationSimpson, G. M. / Kingsbury, S. J. et al. | 2002
- 235
-
EDITORIAL: Discontinue After Last Dose-An Editorial and Information About Prescription WritingShader, R. I. et al. | 2002
- 236
-
Clozapine Use and Risk of Diabetes MellitusWang, P. S. / Glynn, R. J. / Ganz, D. A. / Schneeweiss, S. / Levin, R. / Avorn, J. et al. | 2002
- 244
-
Antipsychotic-Induced Weight Gain and Therapeutic Response: A Differential AssociationCzobor, P. / Volavka, J. / Sheitman, B. / Lindenmayer, J.-P. / Citrome, L. / McEvoy, J. / Cooper, T. B. / Chakos, M. / Lieberman, J. A. et al. | 2002
- 252
-
High Serum Creatinine Kinase Level: Possible Risk Factor for Neuroleptic Malignant SyndromeHermesh, H. / Manor, I. / Shiloh, R. / Aizenberg, D. / Benjamini, Y. / Munitz, H. / Weizman, A. et al. | 2002
- 257
-
Fluoxetine in Social Phobia: A Double-Blind, Placebo-Controlled Pilot StudyKobak, K. A. / Greist, J. H. / Jefferson, J. W. / Katzelnick, D. J. et al. | 2002
- 263
-
Fluoxetine Alone in the Treatment of First Episode Anxious-Depression: An Open Clinical TrialSpalletta, G. / Pasini, A. / Caltagirone, C. et al. | 2002
- 267
-
Anxiety and Depression Symptoms and Response to Methylphenidate in Children With Attention-Deficit Hyperactivity Disorder and Tic DisorderGadow, K. D. / Nolan, E. E. / Sverd, J. / Sprafkin, J. / Schwartz, J. et al. | 2002
- 275
-
Interactive Model of Therapeutic Response in Panic Disorder: Moclobemide, a Case in PointUhlenhuth, E. H. / Warner, T. D. / Matuzas, W. et al. | 2002
- 285
-
Long-Term Benzodiazepine Use and Cognitive Decline in the Elderly: The Epidemiology of Vascular Aging StudyPaterniti, S. / Dufouil, C. / Alperovitch, A. et al. | 2002
- 294
-
Duration of Imipramine Therapy and Relapse in Panic Disorder With AgoraphobiaMavissakalian, M. R. / Perel, J. M. et al. | 2002
- 300
-
Antipanic Drug Modulation Of 35% CO~2 Hyperreactivity and Short-Term Treatment OutcomePerna, G. / Bertani, A. / Caldirola, D. / Gabriele, A. / Cocchi, S. / Bellodi, L. et al. | 2002
- 309
-
Multivariate Meta-Analysis of Controlled Drug Studies for Obsessive-Compulsive DisorderAckerman, D. L. / Greenland, S. et al. | 2002
- 318
-
Effects of Interrater Reliability of Psychopathologic Assessment on Power and Sample Size Calculations in Clinical TrialsMuller, M. J. / Szegedi, A. et al. | 2002
- 326
-
Treatment of Codeine Dependence With Inhibitors of Cytochrome P450 2D6Fernandes, L. C. / Kilicarslan, T. / Kaplan, H. L. / Tyndale, R. F. / Sellers, E. M. / Romach, M. K. et al. | 2002
- 330
-
Designer Drugs That Are Potent Inhibitors of CYP2D6Pritzker, D. / Kanungo, A. / Kilicarslan, T. / Tyndale, R. F. / Sellers, E. M. et al. | 2002
- 343
-
Treatment-Resistant Mood DisordersPies, R. et al. | 2002
- 345
-
GUEST EDITORIAL: Electroconvulsive Therapy in Clinical PsychopharmacologyPearlman, C. et al. | 2002
- 347
-
Therapeutic Tolerance and Rebound Psychosis During Quetiapine Maintenance Monotherapy in Patients With Schizophrenia and Schizoaffective DisorderMargolese, H. C. / Chouinard, G. / Beauclair, L. / Belanger, M.-C. et al. | 2002
- 353
-
Influences of Patient-Related Variables on Risperidone Efficacy for Acutely Exacerbated Schizophrenia: Analyses With Rigorous StatisticsLane, H.-Y. / Chang, Y.-C. / Chiu, C.-C. / Chen, T.-T. / Lee, S.-H. / Chang, W.-H. et al. | 2002
- 359
-
Effects of Typical and Atypical Antipsychotics on the Prepulse Inhibition of the Startle Reflex in Patients With SchizophreniaOranje, B. / van Oel, C. J. / Wied, C. C. G.-d. / Verbaten, M. N. / Kahn, R. S. et al. | 2002
- 366
-
Influence of Ritonavir on Olanzapine Pharmacokinetics in Healthy VolunteersPenzak, S. R. / Hon, Y. Y. / Lawhorn, W. D. / Shirley, K. L. / Spratlin, V. / Jann, M. W. et al. | 2002
- 371
-
The Impact of CYP2C19 and CYP2D6 Genotypes on Metabolism of Amitriptyline in Japanese Psychiatric PatientsShimoda, K. / Someya, T. / Yokono, A. / Morita, S. / Hirokane, G. / Takahashi, S. / Okawa, M. et al. | 2002
- 379
-
Double-Blind Study of High-Dose Fluoxetine Versus Lithium or Desipramine Augmentation of Fluoxetine in Partial and Nonresponders to FluoxetineFava, M. / Alpert, J. / Nierenberg, A. / Lagomasino, I. / Sonawalla, S. / Tedlow, J. / Worthington, J. / Baer, L. / Rosenbaum, J. F. et al. | 2002
- 388
-
Effects of Reboxetine on Anxiety, Agitation, and Insomnia: Results of a Pooled Evaluation of Randomized Clinical TrialsStahl, S. M. / Mendels, J. / Schwartz, G. E. et al. | 2002
- 393
-
Reboxetine, a New Noradrenaline Selective Antidepressant, Is at Least as Effective as Fluoxetine in the Treatment of DepressionAndreoli, V. / Caillard, V. / Deo, R. S. / Rybakowski, J. K. / Versiani, M. et al. | 2002
- 400
-
Effect of Citalopram Treatment on Relationship Between Platelet Serotonin Functions and the Karolinska Scales of Personality in Panic PatientsNeuger, J. / Wistedt, B. / Aberg-Wistedt, A. / Stain-Malmgren, R. et al. | 2002
- 406
-
Serum Levels of Citalopram and Its Main Metabolites in Adolescent Patients Treated in a Naturalistic Clinical SettingReis, M. / Olsson, G. / Carlsson, B. / Lundmark, J. / Dahl, M.-L. / Walinder, J. / Ahlner, J. / Bengtsson, F. et al. | 2002
- 414
-
A Typological Model for Estimation of Drug and Placebo Effects in DepressionRoss, D. C. / Quitkin, F. M. / Klein, D. F. et al. | 2002
- 419
-
Inhibition of Risperidone Metabolism by Fluoxetine in Patients With Schizophrenia: A Clinically Relevant Pharmacokinetic Drug InteractionSpina, E. / Avenoso, A. / Scordo, M. G. / Ancione, M. / Madia, A. / Gatti, G. / Perucca, E. et al. | 2002
- 424
-
Pronounced Early Increase in Circulating Leptin Predicts a Lower Weight Gain During Clozapine TreatmentMonteleone, P. / Fabrazzo, M. / Tortorella, A. / La Pia, S. / Maj, M. et al. | 2002
- 427
-
How Long Should the Lithium Augmentation Strategy be Maintained? A 1-Year Follow-up of a Placebo-Controlled Study in Unipolar Refractory Major DepressionBschor, T. / Berghofer, A. / Strohle, A. / Kunz, D. / Adli, M. / Muller-Oerlinghausen, B. / Bauer, M. et al. | 2002
- 431
-
Use of Topiramate in Treatment-Resistant Bipolar Spectrum DisordersVieta, E. / Torrent, C. / Garcia-Ribas, G. / Gilabert, A. / Garcia-Pares, G. / Rodriguez, A. / Cadevall, J. / Garcia-Castrillon, J. / Lusilla, P. / Arrufat, F. et al. | 2002
- 445
-
GUEST EDITORIAL: Have We Undersold Lithium for Bipolar Disorder?Pies, R. et al. | 2002
- 450
-
Treatment of Bipolar I Rapid Cycling Patients during Dysphoric Mania with OlanzapineGonzalez-Pinto, A. / Tohen, M. / Lalaguna, B. / Perez-Heredia, J. L. / Fernandez-Corres, B. / Gutierrez, M. / Mico, J. A. et al. | 2002
- 455
-
Open-Label Study of Olanzapine in Children with Pervasive Developmental DisorderKemner, C. / Willemsen-Swinkels, S. H. N. / de Jonge, M. / Tuynman-Qua, H. / van Engeland, H. et al. | 2002
- 461
-
Risperidone-Induced Obsessive-Compulsive Symptoms: A Series of Six Cases Basil AlevizosLykouras, L. / Zervas, I. M. / Christodoulou, G. N. et al. | 2002
- 468
-
Comparative Efficacy of Adderall and Methylphenidate in Attention-deficit/Hyperactivity Disorder: A Meta-AnalysisFaraone, S. V. / Biederman, J. / Roe, C. et al. | 2002
- 474
-
The Effects of Adding Cognitive Therapy to Fluoxetine Dose Increase on Risk of Relapse and Residual Depressive Symptoms in Continuation Treatment of Major Depressive DisorderPerlis, R. H. / Nierenberg, A. A. / Alpert, J. E. / Pava, J. / Matthews, J. D. / Buchin, J. / Sickinger, A. H. / Fava, M. et al. | 2002
- 481
-
Effect of Nortriptyline and Paroxetine on CYP2D6 Activity in Depressed Elderly PatientsSolai, L. K. / Pollock, B. G. / Mulsant, B. H. / Frye, R. F. / Miller, M. D. / Sweet, R. A. / Kirshner, M. / Sorisio, D. / Begley, A. / Reynolds, C. F. et al. | 2002
- 487
-
Nicotine Replacement to Reduce Cigarette Consumption in Smokers Who Are Unwilling to Quit: A Randomized TrialEtter, J.-F. / Laszlo, E. / Zellweger, J.-P. / Perrot, C. / Perneger, T. V. et al. | 2002
- 496
-
Total Cotinine in Plasma: A Stable Biomarker for Exposure to Tobacco Smokede Leon, J. / Diaz, F. J. / Rogers, T. / Browne, D. / Dinsmore, L. / Ghosheh, O. H. / Dwoskin, L. P. / Crooks, P. A. et al. | 2002
- 502
-
Fluvoxamine Augmentation of Olanzapine in Chronic Schizophrenia: Pharmacokinetic Interactions and Clinical EffectsHiemke, C. / Peled, A. / Jabarin, M. / Hadjez, J. / Weigmann, H. / Hartter, S. / Modai, I. / Ritsner, M. / Silver, H. et al. | 2002
- 507
-
Controlled Trial of Hydroxychloroquine in SchizophreniaDesta, M. / Tadesse, A. / Gebre, N. / Barci, B. M. / Torrey, E. F. / Knable, M. B. et al. | 2002
- 511
-
Tolerance to Daytime Sedative Effects of H1 AntihistaminesRichardson, G. S. / Roehrs, T. A. / Rosenthal, L. / Koshorek, G. / Roth, T. et al. | 2002
- 516
-
Allopregnanolone Levels and Symptom Improvement in Severe Premenstrual SyndromeFreeman, E. W. / Frye, C. A. / Rickels, K. / Martin, P. A. G. / Smith, S. S. et al. | 2002
- 524
-
Add-On Combination and Maintenance Treatment: Case Series of Five Obese Patients with Different Eating BehaviorAnghelescu, I. / Klawe, C. / Szegedi, A. et al. | 2002
- 525
-
Re: Clomipramine vs. Haloperidol in the Treatment of Autistic Disorder: A Double-blind, Placebo, Crossover StudyKing, R. / Fay, G. / Wheildon, H. et al. | 2002
- 526
-
Reply to Dr. King and AssociatesSloman, L. / Konstantareas, M. / Remington, G. et al. | 2002
- 527
-
Comments on In Vitro and In Vivo Studies of Fluvoxamine-Clozapine InteractionOlesen, O. V. / Linnet, K. et al. | 2002
- 529
-
Combination of Olanzapine and Divalproex for Agitation in Individuals with Profound Mental RetardationOlson, D. A. / Ingram, W. / Mann, J. R. et al. | 2002
- 530
-
Effects of Olanzapine Plasma Concentrations on Depressive Symptoms in Schizophrenia: A Pilot StudyLane, H.-Y. / Guo, S.-C. / Hwang, T.-J. / Chen, Y.-S. / Cheng, J. J. / Lee, Y.-C. / Hong, C.-J. / Hwu, H.-G. / Chang, W.-H. et al. | 2002
- 532
-
Sexual Side Effects Associated with ValproateSchneck, C. D. / Thomas, M. R. / Gundersen, D. et al. | 2002
- 534
-
Antidepressant-related Hypomania in a Patient with Premenstrual Dysphoric DisorderHsiao, M.-C. / Liu, C.-Y. et al. | 2002
- 536
-
Novel Antipsychotics and Severe Hyperlipidemia: Comments on the Meyer PaperBaptista, T. / Kin, N. M. K. N. Y. / Beaulieu, S. et al. | 2002
- 538
-
Re: Prolactin Levels and Adverse Events in Patients Treated with RisperidoneDenisov, M. F. et al. | 2002
- 538
-
Reply to Comments by Drs. Baptista, Kin, and Beaulieu on Novel Antipsychotics and Severe HyperlipidemiaMeyer, J. et al. | 2002
- 541
-
GUEST EDITORIAL: Fostering Treatment AdvancesKlein, D. F. et al. | 2002
- 543
-
IN MEMORIAM: Richard Jed Wyatt, MD (1939-2002)Weinberger, D. R. et al. | 2002
- 545
-
Switching Outpatients With Schizophrenia and Related Disorders on Long-Acting Injectable Antipsychotics to Olanzapine: An Open-Label Naturalistic Pilot StudyLabelle, A. / Bourget, D. / Boulay, L. J. / Ellis, J. / Tessier, P. et al. | 2002
- 554
-
Dose-Related Effects of Amisulpride on Five Dimensions of Psychopathology in Patients With Acute Exacerbation of SchizophreniaMuller, M. J. / Wetzel, H. / Eich, F.-X. / Rein, W. / Puech, A. / Benkert, O. / Amisulpride Study Group et al. | 2002
- 561
-
Effectiveness of Venlafaxine, Extended Release Formulation, in the Short-Term and Long-Term Treatment of Generalized Anxiety Disorder: Results of a Survival AnalysisMontgomery, S. A. / Mahe, V. / Haudiquet, V. / Hackett, D. et al. | 2002
- 568
-
Fluoxetine Pharmacokinetics in Pediatric PatientsWilens, T. E. / Cohen, L. / Biederman, J. / Abrams, A. / Neft, D. / Faird, N. / Sinha, V. et al. | 2002
- 576
-
Residual Effects of Middle-of-the-Night Administration of Zaleplon and Zolpidem on Driving Ability, Memory Functions, and Psychomotor PerformanceVerster, J. C. / Volkerts, E. R. / Schreuder, A. H. C. M. L. / Eijken, E. J. E. / van Heuckelum, J. H. G. / Veldhuijzen, D. S. / Verbaten, M. N. / Paty, I. / Darwish, M. / Danjou, P. et al. | 2002
- 584
-
Effectiveness of Adjunctive Gabapentin in Resistant Bipolar Disorder: Is It Due to Anxious-Alcohol Abuse Comorbidity?Perugi, G. / Toni, C. / Frare, F. / Ruffolo, G. / Moretti, L. / Torti, C. / Akiskal, H. S. et al. | 2002
- 592
-
Lack of Efficacy of Naltrexone in the Prevention of Alcohol Relapse: Results From a German Multicenter StudyGastpar, M. / Bonnet, U. / Boning, J. / Mann, K. / Schmidt, L. G. / Soyka, M. / Wetterling, T. / Kielstein, V. / Labriola, D. / Croop, R. et al. | 2002
- 599
-
Review of the Use of Topiramate for Treatment of Bipolar DisordersSuppes, T. et al. | 2002
- 610
-
Symptom Severity and Exclusion From Antidepressant Efficacy TrialsZimmerman, M. / Posternak, M. A. / Chelminski, I. et al. | 2002
- 615
-
Regional Effects of Donepezil and Rivastigmine on Cortical Acetylcholinesterase Activity in Alzheimer's DiseaseKaasinen, V. / Nagren, K. / Jarvenpaa, T. / Roivainen, A. / Yu, M. / Oikonen, V. / Kurki, T. / Rinne, J. O. et al. | 2002
- 621
-
Clozapine and Oral Contraceptives: A Possible Drug InteractionGabbay, V. / O Dowd, M. A. / Mamamtavrishvili, M. / Asnis, G. M. et al. | 2002
- 622
-
5HT2A and 5HT2C Receptor Polymorphisms and Predicting Clinical Response to Olanzapine in SchizophreniaEllingrod, V. L. / Perry, P. J. / Lund, B. C. / Bever-Stille, K. / Fleming, F. / Holman, T. L. / Miller, D. et al. | 2002
- 624
-
Neuroleptic Malignant Syndrome with ZiprasidoneMurty, R. G. / Mistry, S. G. / Chacko, R. C. et al. | 2002
- 626
-
Dosing Strategies of Clozapine-Fluvoxamine CotreatmentLu, M.-L. / Lane, H.-Y. / Jann, M. W. / Chang, W.-H. et al. | 2002
- 629
-
Can Risperidone Reduce Cocaine Use in Substance Abusing Schizophrenic Patients?Tsuang, J. W. / Eckman, T. / Marder, S. / Tucker, D. et al. | 2002
- 630
-
Seizure and Cardiac Arrest During Bupropion SR TreatmentBergmann, F. / Bleich, S. / Wischer, S. / Paulus, W. et al. | 2002
- 631
-
Valproate-induced HyperammonaemiaRaja, M. / Azzoni, A. et al. | 2002
- 633
-
Oral Methylphenidate-Alcohol Co-abuseBarrett, S. P. / Pihl, R. O. et al. | 2002